Juno Therapeutics is a prominent venture capital fund based in Seattle, Washington, founded in 2013 The firm specializes in advancing innovative therapies in the field of immuno-oncology With a significant investment scale of $264,600,000, Juno Therapeutics is dedicated to developing groundbreaking treatments for cancer The organization focuses on harnessing the power of the immune system to provi...